Rendering

Component: (Network and Table)
Network
2414405 - Disclosure - Equity-Based Compensation - Weighted-Average Fair Value Assumptions, Stock Option Activity (Details)
(http://www.amagpharma.com/role/EquityBasedCompensationWeightedAverageFairValueAssumptionsStockOptionActivityDetails)
TableSchedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Slicers (applies to each fact value in each table cell)
Equity compensation plansPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Award Type [Axis]Award Type [Axis]Award Type [Axis]
EmployeesNon Employee DirectorsEmployeesNon Employee DirectorsEmployeesNon Employee Directors
Risk free interest rate (%)
1.32%  
1.10%  
1.55%  
1.24%  
1.56%  
1.28%  
Expected volatility (%)
49.00%  
54.00%  
47.00%  
46.00%  
47.00%  
46.00%  
Expected option term (years)
P5Y  
P3Y  
P5Y  
P4Y  
P5Y  
P4Y  
Dividend yield
0.00%  
0.00%  
0.00%  
0.00%  
0.00%  
0.00%